Spongiform Encephalopathy

Company's treatment for prion diseases including mad cow disease to be tested

Published in TB and Outbreaks Week, January 4th, 2005

GenoMed, Inc., (GMED), announced that it is collaborating with British and Japanese experts to test the company's patent-pending treatment for prion diseases, also known as transmissible spongiform encephalopathies.

Bovine spongiform encephalopathy (mad cow disease) is the best-known disease in this group.

Dr. Nikolai G. Rainov, a neurosurgeon at the Walton Centre for Neurology and Neurosurgery NHS Trust and the University of Liverpool, will participate in testing GenoMed's patent-pending approach in animal models. Dr. Katsumi Doh-ura's research group at Tohoku University in Sendai, Japan will carry out all animal experiments.

...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2005-01-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry